Skip to main content
. 2023 Jun 30;43:33. doi: 10.1186/s41232-023-00287-1

Fig. 4.

Fig. 4

Preparation and characteristics of iPS-MnO2@Ce6 as drug carriers [12]. A Schematic representation of the preparation process of iPS-MnO2@Ce6. B Confocal laser scanning microscopy images of iPSCs treated with Ce6 and MnO2@Ce6. C Representative transmission electron microscope images of iPSCs incubated with nanoprobes. The red arrows indicate the nanoprobe without degradation, and the green indicates the nanoprobe with degradation. Reproduced from Liu et al. with permission from Springer, Copyright 2020